38th week of 2018 patent applcation highlights part 24 |
Patent application number | Title | Published |
20180265484 | HEPATITIS B CORE PROTEIN MODULATORS | 2018-09-20 |
20180265485 | ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS | 2018-09-20 |
20180265486 | ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS | 2018-09-20 |
20180265487 | SWEET TASTE MODULATORS | 2018-09-20 |
20180265488 | OXIDATION CHEMISTRY ON FURAN ALDEHYDES | 2018-09-20 |
20180265489 | NOVEL ANTICANCER AGENT | 2018-09-20 |
20180265490 | METHODS FOR PRODUCING BERAPROST AND ITS DERIVATIVES | 2018-09-20 |
20180265491 | INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 | 2018-09-20 |
20180265492 | ANTIFUNGAL COMPOUNDS AND PROCESSES FOR MAKING | 2018-09-20 |
20180265493 | PROCESS FOR MAKING M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | 2018-09-20 |
20180265494 | SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS | 2018-09-20 |
20180265495 | NEW CRYSTAL FORM OF NERATINIB MALEATE AND PREPARATION METHOD THEREFOR | 2018-09-20 |
20180265496 | SUBSTITUTED QUINOLONE DERIVATIVES, OR PHARMACEUTICALLY ACCEPTABLE SALTS OR STEREOISOMERS THEREOF, AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | 2018-09-20 |
20180265497 | PYRIMIDINYL-PYRIDYLOXY-NAPHTHYL COMPOUNDS AND METHODS OF TREATING IRE1-RELATED DISEASES AND DISORDERS | 2018-09-20 |
20180265498 | 1,4-DI-(4-METHYLTHIOPHENYL)-3-PHTALOYLAZETIDINE-2-ONE AND THE DERIVATIVES THEREOF | 2018-09-20 |
20180265499 | BIARYL PIPERIDINE AMIDE COMPOUNDS AND METHODS OF USE THEREOF | 2018-09-20 |
20180265500 | TETRAHYDROQUINOLINE SULFONAMIDE DERIVATIVES AS INVERSE AGONISTS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T)) | 2018-09-20 |
20180265501 | CYCLOPROPANECARBOXAMIDE MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | 2018-09-20 |
20180265502 | TETRAHYDROQUINOLINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE | 2018-09-20 |
20180265503 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | 2018-09-20 |
20180265504 | AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES | 2018-09-20 |
20180265505 | PROCESS FOR THE PREPARATION OF N-[(3-AMINOOXETAN-3-YL) METHYL]-2-(1,1-DIOXO-3,5-DIHYDRO-1,4-BENZOTHIAZEPIN-4-YL)-6-METHYL-QUINAZ- OLIN-4-AMINE | 2018-09-20 |
20180265506 | BENZYL AMINE-CONTAINING HETEROCYCLIC COMPOUNDS AND COMPOSITIONS USEFUL AGAINST MYCOBACTERIAL INFECTION | 2018-09-20 |
20180265507 | HOST TARGETED INHIBITORS OF DENGUE VIRUS AND OTHER VIRUSES | 2018-09-20 |
20180265508 | CRYSTALLINE FORMS OF A COMPOUND THAT INHIBITS BROMODOMAIN | 2018-09-20 |
20180265509 | Tetrahydro-Pyrido-Pyrimidine Derivatives | 2018-09-20 |
20180265510 | 6,7-CYCLICMORPHINAN DERIVATIVES AND USE THEREOF | 2018-09-20 |
20180265511 | COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES | 2018-09-20 |
20180265512 | FUSED PYRIMIDINE-BASED HYDROXAMATE DERIVATIVES | 2018-09-20 |
20180265513 | NOVEL PROCESS FOR THE PREPARATION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ENZYME INHIBITOR | 2018-09-20 |
20180265514 | SALT OF CD80 ANTAGONIST | 2018-09-20 |
20180265515 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF | 2018-09-20 |
20180265516 | Substituted triazolopiperazine PARP inhibitor, preparation method therefor and use thereof | 2018-09-20 |
20180265517 | EZH2 Inhibitors | 2018-09-20 |
20180265518 | APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF | 2018-09-20 |
20180265519 | TRICYCLIC PROTEASOME ACTIVITY ENHANCING COMPOUNDS | 2018-09-20 |
20180265520 | MONOCYCLIC THIENO, PYRIDO, AND PYRROLO PYRIMIDINE COMPOUNDS AND METHODS OF USE AND MANUFACTURE OF SAME | 2018-09-20 |
20180265521 | LIBRARIES OF HETEROARYL-CONTAINING MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | 2018-09-20 |
20180265522 | MARINOPYRROLE DERIVATIVES AND METHODS OF MAKING AND USING SAME | 2018-09-20 |
20180265523 | ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS | 2018-09-20 |
20180265524 | SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS | 2018-09-20 |
20180265525 | POLYCYCLIC PYRIDONE DERIVATIVE HAVING INTEGRASE INHIBITORY ACTIVITY | 2018-09-20 |
20180265526 | ORGANIC METAL COMPOUND-CONTAINING COMPOSITION | 2018-09-20 |
20180265527 | Acyl Germanium Photoinitiators And Process For The Preparation Thereof | 2018-09-20 |
20180265528 | NOVEL BRANCHED AMPHIPHILIC LIPIDS | 2018-09-20 |
20180265529 | PROCESS FOR PRODUCING PHOSPHINATES | 2018-09-20 |
20180265530 | CRYSTALLINE FORMS OF TENOFOVIR ALAFENAMIDE | 2018-09-20 |
20180265531 | TC-PTP INHIBITORS AS APC ACTIVATORS FOR IMMUNOTHERAPY | 2018-09-20 |
20180265532 | METAL CARBENE OLEFIN METATHESIS CATALYSTS | 2018-09-20 |
20180265533 | SYNTHESIS OF MONOETHERS OF SUGAR COMPRISING A LONG ALKYL CHAIN AND USES THEREOF AS A SURFACTANT | 2018-09-20 |
20180265534 | MULTI-FUNCTIONALIZED POLYSACCHARIDE COMPOUNDS AND USE THEREOF FOR TARGETING THE CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR | 2018-09-20 |
20180265535 | AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS | 2018-09-20 |
20180265536 | Use Of Avermectin Derivative For Increasing Bioavailability And Efficacy Of Macrocyclic Lactones | 2018-09-20 |
20180265537 | Nucleoside Triphosphates with Stable Aminoxy Groups | 2018-09-20 |
20180265538 | THIOL COMPOUNDS AND THE USE THEREOF FOR THE SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES | 2018-09-20 |
20180265539 | TRANSITION METAL MOLYBDOTUNGSTEN OXY-HYDROXIDE | 2018-09-20 |
20180265540 | SYNTHESIS OF ESTETROL VIA ESTRONE DERIVED STEROIDS | 2018-09-20 |
20180265541 | PRODRUGS OF 17.BETA.-HSD1-INHIBITORS | 2018-09-20 |
20180265542 | LIGAND FUNCTIONALIZED POLYMERS | 2018-09-20 |
20180265543 | METHOD OF PURIFYING AN ANTIBODY | 2018-09-20 |
20180265544 | SEPARATION METHOD FOR FUCOSYLATED ANTIBODIES | 2018-09-20 |
20180265545 | Genetic system for producing a proteases inhibitor of a small peptide aldehyde type | 2018-09-20 |
20180265546 | SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS | 2018-09-20 |
20180265547 | Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES | 2018-09-20 |
20180265548 | LIGANDS FOR INTEGRIN AV 6, SYNTHESIS AND USES THEREOF | 2018-09-20 |
20180265549 | CYCLIC POLYPEPTIDES, METHOD FOR OBTAINING THEM AND THE THERAPEUTIC USE THEREOF | 2018-09-20 |
20180265550 | THERAPIES, VACCINES, AND PREDICTIVE METHODS FOR FLAVIVIRUSES | 2018-09-20 |
20180265551 | CYTOMEGALOVIRUS ANTIGENS | 2018-09-20 |
20180265552 | NEPOVIRUS COAT PROTEIN FUSION POLYPEPTIDES AND THEIR USE | 2018-09-20 |
20180265553 | VACCINE ANTIGEN WITH INCREASED IMMUNOGENICITY | 2018-09-20 |
20180265554 | USE OF A POLYPEPTIDE FOR EFFECTING IMMUNE SIGNALLING AND/OR AFFECTING INTESTINAL BARRIER FUNCTION AND/OR MODULATING METABOLIC STATUS | 2018-09-20 |
20180265555 | Method for Producing Fibroin-Like Protein | 2018-09-20 |
20180265556 | NOVEL DERMATOPHAGOIDES FARINAE PROTEIN | 2018-09-20 |
20180265557 | Complement split product C4d for the treatment of inflammatory conditions | 2018-09-20 |
20180265558 | MODIFIED FIBROBLAST GROWTH FACTOR 1 (FGF-1) POLYPEPTIDES WITH INCREASED BINDING AFFINITY FOR HEPARIN AND ASSOCIATED METHODS | 2018-09-20 |
20180265559 | POLYPEPTIDES, NUCLEIC ACIDS AND USES THEREOF | 2018-09-20 |
20180265560 | BIPHASIC SINGLE-CHAIN INSULIN ANALOGUES | 2018-09-20 |
20180265561 | FREEZE-DRIED PREPARATION CONTAINING HIGH-PURITY PTH AND METHOD FOR PRODUCING SAME | 2018-09-20 |
20180265562 | Consumable Cryopreserved Cells Transiently Overexpressing Gene(s) Encoding Drug Transporter Protein(s) and/or Drug Metabolizing Enzyme(s) | 2018-09-20 |
20180265563 | Consumable Cryopreserved Cells Transiently Overexpressing Gene(s) Encoding Drug Transporter Protein(s) and/or Drug Metabolizing Enzyme(s) | 2018-09-20 |
20180265564 | METHOD FOR PRODUCING SOLUBLE FcR AS Fc-FUSION WITH INERT IMMUNOGLOBULIN Fc-REGION AND USES THEREOF | 2018-09-20 |
20180265565 | Method of Redirecting T Cells to Treat HIV Infection | 2018-09-20 |
20180265566 | METHODS FOR CONTROLLING T CELL PROLIFERATION | 2018-09-20 |
20180265567 | IL-33 Antagonists and Uses Thereof | 2018-09-20 |
20180265568 | ALBUMIN VARIANTS AND CONJUGATES | 2018-09-20 |
20180265569 | ALBUMIN VARIANTS | 2018-09-20 |
20180265570 | ALBUMIN VARIANTS | 2018-09-20 |
20180265571 | HETEROLOGOUS TARGETING PEPTIDE GRAFTED AAVS | 2018-09-20 |
20180265572 | MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS | 2018-09-20 |
20180265573 | ANTIBODIES AGAINST INFLUENZA VIRUS HEMAGGLUTININ AND USES THEREOF | 2018-09-20 |
20180265574 | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection | 2018-09-20 |
20180265575 | ANTI-PHF-TAU ANTIBODIES AND USES THEREOF | 2018-09-20 |
20180265576 | ANTIBODIES TO OXIDIZED PHOSPHOLIPIDS | 2018-09-20 |
20180265577 | ANTIBODIES TO TAU AND USES THEREOF | 2018-09-20 |
20180265578 | ANTIBODY TO GDF8 AND USES THEREOF | 2018-09-20 |
20180265579 | TREATMENT OF FIBROSIS | 2018-09-20 |
20180265580 | NOVEL P2X7 EPITOPES | 2018-09-20 |
20180265581 | JAML Specific Binding Agents, Antibodies, and Uses Related Thereto | 2018-09-20 |
20180265582 | Immunological Reagents | 2018-09-20 |
20180265583 | HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE FOR THE DIAGNOSIS AND TREATMENT OF COLON AND PANCREAS CANCER | 2018-09-20 |